Phenotypic and Molecular Characterisation of Staphylococcus Aureus with Reduced Vancomycin Susceptibility Derivated in Vitro

Vancomycin has been the primary agent used to treat serious Methicillin-resistant Staphylococcus aureus (MRSA) infection for many years. However, the rise of MRSA infection rates and the extensive use of vancomycin have led to the emergence of reduced vancomycin susceptibility. Therefore, four typic...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Open Med (Wars)
Egile Nagusiak: Xu, Jia, Pang, Long, Ma, Xiao Xue, Hu, Jian, Tian, Yuan, Yang, Ya Li, Sun, Dan Dan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: De Gruyter 2018
Gaiak:
Regular Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6227741/
https://ncbi.nlm.nih.gov/pubmed/30426085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/med-2018-0071
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak